Add Company
Join Now

EpiBiologics Revenue and Competitors

License our Company Data API

Location

#4563

Growjo Ranking

Biotech

Industry
Embed

Estimated Revenue & Valuation

  • EpiBiologics's estimated annual revenue is currently $2.6M per year.(i)
  • EpiBiologics's estimated revenue per employee is $77,500
  • EpiBiologics's total funding is $73M.

Employee Data

  • EpiBiologics has 33 Employees.(i)
  • EpiBiologics grew their employee count by 38% last year.

EpiBiologics's People

NameTitleEmail/Phone
1
CEO and Co-FounderReveal Email/Phone
2
Chief Scientific OfficerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.4M57-8%$53MN/A
#2
$21.2M137-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.3M1515%N/AN/A
#5
$1.6M10-17%N/AN/A
#6
$0.7M950%N/AN/A
#7
$11.5M74-12%N/AN/A
#8
$0.4M27510%$236.7MN/A
#9
$4M51-74%$160MN/A
#10
$2.3M1515%N/AN/A
Add Company

What Is EpiBiologics?

EpiBiologics is building a next-generation protein degradation platform that targets membrane and extracellular proteins. EpiBiologics was founded in 2022 based on the pioneering work from academic founder Dr. Jim Wells of the University of California San Francisco (UCSF). The Company’s proprietary EpiTAC platform is a modular antibody-based system that enables the precise degradation of disease-driving membrane and extracellular proteins in a tissue-specific manner. Headquartered in San Mateo, EpiBiologics is backed by leading healthcare investors and aims to develop first-in-class and best-in-class targeted therapies across multiple therapeutic areas. For more information, please visit epibiologics.com and follow us on LinkedIn.

keywords:N/A

$73M

Total Funding

33

Number of Employees

$2.6M

Revenue (est)

38%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$3.5M3310%N/A
#2
$6.5M336%N/A
#3
$3.8M3357%N/A
#4
$3.5M343%N/A
#5
$7.3M346%N/A